Search research articles
Contact Us
Filters
Showing results (51-60 of 103) with videos related to
Page
of 11
Sort By:
Cancer Chemotherapy and Pharmacology
|
November 1, 2011
Feasibility of biweekly combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in patients with metastatic solid tumors: results of a two-step phase I trial: XELIRI and XELIRINOX
T Mazard, M Ychou, S Thezenas, et al.
Annals of Surgery
|
January 1, 1995
Conservative surgery for low rectal carcinoma after high-dose radiation. Functional and oncologic results
P Rouanet, J M Fabre, J B Dubois, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Irinotecan combined with bolus fluorouracil, continuous infusion fluorouracil, and high-dose leucovorin every two weeks (LV5FU2 regimen): a clinical dose-finding and pharmacokinetic study in patients with pretreated metastatic colorectal cancer
M Ducreux, M Ychou, J F Seitz, et al.
British Journal of Cancer
|
November 13, 2003
Potentiation of ionising radiation by targeting tumour necrosis factor alpha using a bispecific antibody in human pancreatic cancer
D Azria, C Larbouret, V Garambois, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Efficacy of combined 5-fluorouracil and cisplatinum in advanced gastric carcinomas. A phase II trial with prognostic factor analysis
P Rougier, M Ducreux, M Mahjoubi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Neoadjuvant chemotherapy in locally advanced gastric carcinoma--a phase II trial with combined continuous intravenous 5-fluorouracil and bolus cisplatinum
P Rougier, M Mahjoubi, P Lasser, et al.
ESMO Open
|
November 27, 2021
Sequential first-line treatment with nab-paclitaxel/gemcitabine and FOLFIRINOX in metastatic pancreatic adenocarcinoma: GABRINOX phase Ib-II controlled clinical trial
E Assenat, C de la Fouchardière, F Portales, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 6, 2007
A randomized phase II trial evaluating safety and efficacy of an experimental chemotherapy regimen (irinotecan + oxaliplatin, IRINOX) and two standard arms (LV5 FU2 + irinotecan or LV5 FU2 + oxaliplatin) in first-line metastatic colorectal cancer: a study of the Digestive Group of the Fédération Nationale des Centres de Lutte Contre le Cancer
Y Bécouarn, P Senesse, S Thézenas, et al.
Pathologie-Biologie
|
October 1, 1990
Radioimmunotherapy of colon carcinoma with I-131 labeled antibodies, successful experimental results and clinical dosimetry study
J P Mach, F Buchegger, A Pelegrin, et al.
Gastroenterologie Clinique Et Biologique
|
March 29, 2001
[Contribution of endorectal ultrasonography in preoperative evaluation for very low rectal cancer]
P Senesse, F Khemissa, C Lemanski, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 103) with videos related to
Sort By:
Page
of 11
Cancer Chemotherapy and Pharmacology
|
November 1, 2011
Feasibility of biweekly combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in patients with metastatic solid tumors: results of a two-step phase I trial: XELIRI and XELIRINOX
T Mazard, M Ychou, S Thezenas, et al.
Annals of Surgery
|
January 1, 1995
Conservative surgery for low rectal carcinoma after high-dose radiation. Functional and oncologic results
P Rouanet, J M Fabre, J B Dubois, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Irinotecan combined with bolus fluorouracil, continuous infusion fluorouracil, and high-dose leucovorin every two weeks (LV5FU2 regimen): a clinical dose-finding and pharmacokinetic study in patients with pretreated metastatic colorectal cancer
M Ducreux, M Ychou, J F Seitz, et al.
British Journal of Cancer
|
November 13, 2003
Potentiation of ionising radiation by targeting tumour necrosis factor alpha using a bispecific antibody in human pancreatic cancer
D Azria, C Larbouret, V Garambois, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Efficacy of combined 5-fluorouracil and cisplatinum in advanced gastric carcinomas. A phase II trial with prognostic factor analysis
P Rougier, M Ducreux, M Mahjoubi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Neoadjuvant chemotherapy in locally advanced gastric carcinoma--a phase II trial with combined continuous intravenous 5-fluorouracil and bolus cisplatinum
P Rougier, M Mahjoubi, P Lasser, et al.
ESMO Open
|
November 27, 2021
Sequential first-line treatment with nab-paclitaxel/gemcitabine and FOLFIRINOX in metastatic pancreatic adenocarcinoma: GABRINOX phase Ib-II controlled clinical trial
E Assenat, C de la Fouchardière, F Portales, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 6, 2007
A randomized phase II trial evaluating safety and efficacy of an experimental chemotherapy regimen (irinotecan + oxaliplatin, IRINOX) and two standard arms (LV5 FU2 + irinotecan or LV5 FU2 + oxaliplatin) in first-line metastatic colorectal cancer: a study of the Digestive Group of the Fédération Nationale des Centres de Lutte Contre le Cancer
Y Bécouarn, P Senesse, S Thézenas, et al.
Pathologie-Biologie
|
October 1, 1990
Radioimmunotherapy of colon carcinoma with I-131 labeled antibodies, successful experimental results and clinical dosimetry study
J P Mach, F Buchegger, A Pelegrin, et al.
Gastroenterologie Clinique Et Biologique
|
March 29, 2001
[Contribution of endorectal ultrasonography in preoperative evaluation for very low rectal cancer]
P Senesse, F Khemissa, C Lemanski, et al.
Page
of 11